Genistein, at non-cytotoxic concentrations, was reported to reduce the growth as well as the motility of mouse B16 melanoma cells, through modulation of the activity of enzymes involved in the degradation of the extracellular matrix [i.e., urokinase-type plasminogen activator (uPA)]. The gene discussed is PLAU; the disease is melanoma.